CLINICAL RECOMMENDATIONS |
|
Clinical guidelines (a project): acute respiratory viral infections (ARVI) in adults (short version)
|
7-22 |
|
Kochetkov A.I., Ostroumova O.D., Pereverzev A.P., Martynov A.I., Bakulin I.G., Vertkin A.L., Drozdov V.N., Zyryanov S.K., Kislyak O.A., Lazebnik L.B., Loranskaya I.D., Pogosova N.V., Sychev D.A., Shikh E.V.
Experts consensus on reducing the risk of gastrointestinal bleeding in patients receiving oral anticoagulants
|
23-41 |
ORIGINAL STUDIES |
|
Mazurov V.I., Belyaeva I.B., Sarantseva L.E., Chudinov A.L., Bashkinov R.A., Trofimov Е.А., Gaydukova I.Z., Smulskaya О.А., Inamova O.V., Petrova M.S., Khokhlova Y.V., Vasilenko Е.А., Melnikov Е.S.
Features of the clinical course of rheumatic diseases in patients who have had a new coronavirus infection
|
42-54 |
|
Zamyatina K.N., Saiganov S.A., Mazurov V.I., Gaykovaya L.B., Tkachenko A.N., Urazovskaya I.L., Mansurov D.Sh., Khaidarov V.M., Balgley A.G.
Dynamics of hemostasis system and c-reactive protein indexes while new oral anticoagulants intake in patients after hip joint endoprosthesis replacement
|
55-60 |
|
Gaydukova I.Z., Bashkinov A.R., Inamova O.V.
Topical non-steroidal antiinflammatory medicines in osteoarthritis treatment in patients with concomitant pathology
|
61-68 |
REVIEWS |
|
Vakhlevsky V.V., Tyrenko V.V., Bologov S.G., Kryukov E.V., Toporkov M.M.
The role of interferon gamma in novel coronavirus infection pathogenesis and the possibilities of immune response correction
|
69-77 |
|
Mazurov V.I., Melnikov Е.S., Bashkinov R.A.
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk
|
78-88 |
|
Zhugrova E.S., Mazurov V.I.
Modern principles of osteoporosis therapy
|
89-93 |
|
Salukhov V.V., Khalimov Yu.Sh., Cherkashin D.V., Kadin D.V.
The role of ketonemia induced by sodium-glucose cotransporter 2 inhibitors: from the energy exchange to cardioprotection
|
94-109 |
|
Kokorin V.A.
Acetylsalicylic acid in the treatment of patients with new coronavirus infection (COVID-19): pro and contra
|
110-120 |
GUIDELINES FOR PRACTITIONERS |
|
Gaydukova I.Z., Mazurov V.I., Pilipenko A.I.
Atypical celiac disease with late onset, damage of gastrointestinal tract, nervous and musculoskeletal systems of the organism
|
121-126 |
LECTURE |
|
Zhugrova E.S., Mazurov V.I.
Osteoporosis and comorbidity
|
127-131 |
|
Malyavin A.G.
Vaccine prophylaxis of pneumococcal infection: what a therapist needs to know (overview of the symposium within the XVI National Congress of Internists)
|
132-137 |
|
Mubarakshina O.A.
Possibilities of treatment of patients with physiological and functional pulmonary deficiency symptoms after previous COVID-19 infection (review of the symposium with international participation at the XXXI National Congress on Respiratory Diseases)
|
138-146 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
|
Malyavin A.G.
Consequences of COVID-19: prevalence and approaches to Long-COVID symptoms therapy
|
148-159 |
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Mucins and carbocisteine: respiratory protection
|
160-168 |
|
Malyavin A.G.
Possibilities of acute respiratory viral infections treatment with herbal medicinal products in routine clinical practice
|
169-177 |
|
Posnenkova O.M., Kaluta T.Yu.
Practical issues of oral iron administration for anemia in patients with cardiovascular diseases
|
178-187 |
|
Syrov A.V.
Use of indapamide in clinical practice
|
188-194 |
Activities of RNMOT |
|
Resolution of the expert council of the Russian Scientific Medical Society of Internal Medicine and the Pediatric Respiratory Society «Issues of improving medical care performance to patients with bronchial asthma»
|
196-198 |
|
RSMSIM events plan in January–February 2022
|
199 |
WE REMEMBER |
|
Valeriy Ivanovich SOVALKIN: November 7, 1955 – December 5, 2021
|
200 |
Русский
